Introduction
Children with intellectual disability (ID) have a higher mortality compared with the general population [1] . Genetic syndromes and chromosome aberrations are the main causes of ID, and in some cases, congenital anomalies of the urinary tract and chronic kidney disease (CKD) are associated [2] . While renal transplantation is regarded as the treatment of choice for CKD [3, 4] , its use in patients with ID is less frequent with most patients being treated with dialysis [5] . Renal transplantation in these patients raises a number of questions related not only to outcome but also with regard to the ethics of diverting scarce resources and donor kidneys away from patients with normal mental ability [6, 7] . Ohta et al. and Baqi et al. observed that the outcome of kidney transplantation in patients with ID is acceptable [6, 8] . In this paper, we report our results of renal transplantation in patients with ID over a 5-year period.
Materials and methods
Patients with ID transplanted between 1 January 1997 and 31 December 2006 were studied retrospectively. We selected four age-(±4 years) and date of transplantation-matched (±30 days) controls without ID. Variables were collected until 31 August 2007.
ID was defined as stated by the American Association on Intellectual and Developmental Disabilities [9] . Transplantation was contraindicated in patients unable to take oral medications and lacking family support.
Both groups received a calcineurin inhibitor (CNI) (cyclosporine or tacrolimus), prednisone and an adjuvant drug (azathioprine or mycophenolate mofetil or sirolimus). Patients younger than 18 years old received anti-interleukin 2 receptor (IL-2R). Dose prescriptions and adjustments followed our standardization [10] . CNI C 12 serum levels were checked in all outpatient visits and were used as indicator of adherence. Nonadherence was characterized when cyclosporine or tacrolimus C 12 were below 30 ng/mL or 1.5 ng/dL, respectively, and/or when patients missed >20% of the outpatient evaluations.
Categorical variables were compared using chi-square test or Fisher's exact test, numerical variables with Student's t-test and estimated renal functions [11] with analysis of variance for repetitive measurements. Kaplan-Meier method was used to estimate survivals. Survival curves were compared using log-rank test. Simple and multiple logistic regression were used to estimate the contribution of immunosuppression with adjuvant drugs, CNI, induction therapy, delayed graft function (DGF) and ID upon the risk of infection. A P-value of <0.05 was considered significant. 
Results
The age at time of transplantation, the aetiology of ID, the causative disorder leading to CKD, and the co-morbidities are shown in Table 1 ; demographic characteristics in Table 2 ; and patient and graft survival rates and curves in Table 3 and Figure 1 . Four patients died of infectious causes-two due to septic shock of urinary tract origin (Patient 2 and 15, Table 1 ) and two due to septic shock of unknown origin (Patient 10 and 16, Table 1 )-and one from the control group died due to septic shock of pulmonary origin. All survivors had functioning grafts, whereas among controls, there were 14 graft failures. The complications are shown in Table 4 , and the logistic regressions in Table 5 . Adherence was 100% among patients and 94% among controls. Patients with ID appeared to be less likely [odds ratio (OR) 0.21] to develop infections than controls, P = 0.07. Five years post-transplanta- 
Discussion
Our results suggest that graft survival in patients with ID is equivalent to that observed in patients with no such disability, whereas patient survival is inferior. Benedetti et al. reported on seven patients observed a 100% survival at 5 years [12] . A multi-centre study of 25 patients showed a 100% patient survival at 5 years versus 98.2% among controls [6] . According to United Network of Organ Sharing (UNOS), the patient survival for recipients without ID at 5 years is 85.2% with deceased donors and 92% with live donors [13] . In our institution, 3-year survival was 86.7% and 96.3% for these respective donor types [10] . In the present study, an 81.2% 5-year survival was observed among patients and 97.4% among controls. The possible causes for the worse outcome observed in the study group may be a higher incidence of neoplasia due to genetic abnormalities [14] and immunosuppression [15] .
A major weakness of this study is its retrospective nature with patients and controls not entirely comparable. We observed a lower incidence of acute rejection and a greater survival free of rejection among patients. This may be due to a less intense immune response in these patients [16, 17] . This lower incidence of acute rejection, a powerful risk factor for graft loss [18] , may explain the observed trend towards the increased death-censored graft survival in the study group.
The majority of patients received grafts from deceased donors achieving a 5-year graft survival of 81.2% compared with controls with a 5-year survival close to 70% [13] . This long-term graft survival among recipients with ID came along with an adequate graft function that was similar to controls during all observation period. Thus, although our patients had smaller survival times after transplantation than controls, graft survival and long-term renal function, equivalent to recipients without ID, strengthen renal transplantation as a secure option for treatment of CKD in patients with ID.
The inferior patient survival does not impose restriction to renal transplantation. Renal transplantation in these patients may offer significant advantages when compared to the need for regular dialysis. The need of a full-time caregiver and the extra workload involved with significant emotional distress by the dialysis procedure may indicate that these patients should be prioritized in the waiting lists for a deceased donor. 
